Manufacturer record
Tablets (India) Limited: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
2 batches manufactured by Tablets (India) Limited (Tamil Nadu) were declared Not of Standard Quality between October 2022 and December 2022. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: TTQ2P5, Astyfer XT (Ferrous Ascorbate with Aminoacids, Zinc and Vitamins Tablet I.P.) (exp Jul 2024). CDL Kolkata (CDSCO lab) found it not of standard quality: Disintegration. Listed in the December 2022 alert.
Records by type
2 records linked to Tablets (India) Limited in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Astyfer XT (Ferrous Ascorbate with Aminoacids, Zinc and Vitamins Tablet I.P.) | Batch TTQ2P5Mfg Aug 2022 · Exp Jul 2024 | DisintegrationDisintegration | CDL KolkataCDSCO lab | Dec 2022 |
| TILVIT (Multivitamin Infusion) 10 ml | Batch TAI1D4Mfg Nov 2021 · Exp Jan 2023 | Assay of Vitamin A, Nicotinamide and Thiamine HydrochlorideAssay | CDL KolkataCDSCO lab | Oct 2022 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.